Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy

• Published in: International journal of cardiology 2021-01, Vol.322, p.177-182
• Main Authors: Schiffer, Walter B., Deych, Elena, Lenihan, Daniel J., Zhang, Kathleen W.
• Format: Article
• Language: English
• Subjects: Acute coronary syndrome; Arrhythmia; Heart failure; Immunotherapy; Myocarditis; Pericardial disease
• ISSN: 0167-5273; 1874-1754
• DOI: 10.1016/j.ijcard.2020.08.024

Although the incidence of immune checkpoint inhibitor (ICI)-related cardiovascular (CV) toxicity is low, the overall burden of CV events after ICI is unknown. Risk factors for CV events after ICI have yet to be identified. We sought to evaluate the association between vascular calcification on routine baseline computed tomography (CT) imaging and CV events following ICI. This was a single-center, retrospective cohort study of 76 patients referred to Cardio-Oncology with prior ICI treatment. Coronary and aortic calcification on non-gated chest and abdominal CT imaging were qualitatively assessed. The association of baseline clinical parameters and vascular calcification with symptomatic heart failure (HF), acute coronary syndrome, myocarditis, symptomatic arrhythmia, or pericardial effusion after ICI was evaluated. Over 11 months of follow-up, there were 80 CV events that occurred in 49 patients. Worse coronary and aortic calcification on pre-treatment CT imaging was seen in patients with a CV event (p = .018 and p = .014, respectively). There were no differences in traditional CV risk factors between those with and without a CV event. Eighteen patients (37%) were restarted on ICI therapy after a non- myocarditis or symptomatic systolic HF CV event without recurrent events or mortality over 13 months of follow-up. Symptomatic HF was the most common CV event seen after ICI therapy. Worse coronary and aortic calcification on baseline CT imaging was associated with CV events following ICI. With careful clinical evaluation, selected patients may be re-treated with ICI following a non- myocarditis or symptomatic systolic HF CV event. •A broad range of cardiovascular events may be seen in patients receiving immune checkpoint inhibitor (ICI) therapy.•Vascular calcification on baseline non-gated CT scans are associated with the occurrence of cardiovascular events on ICI therapy.•Selected patients may be re-treated with ICI after a non-myocarditis or symptomatic systolic heart failure event on ICI therapy.